ALPHA TRIBE

GlaxoSmithKline Pharmaceuticals LimitedBoard Meeting, 06-11-2025: Outcome of Board Meeting

06-11-2025 | 04:34 pm

GSK Pharma's board approved Q2 & H1 financial results. Consolidated profit for Q2 hit ₹257.49 Cr & H1 ₹462.50 Cr. They're also investing ₹1.74 Cr in a solar power project at Nashik for green energy and cost savings.

No comments yet. Be the first to comment!

All announcements from GlaxoSmithKline Pharmaceuticals Limited